Alexandra Balcom
Independent DirectorMs. Alexandra Balcom, also known as Alex, MBA, CPA, serves as Independent Director of Crescent Biopharma Inc. since November 2024. Ms. Balcom served as Chief Financial Officer of Nuvalent, Inc. from January 2021 to July 15, 2026 and also serves as its Treasurer. She held various roles at SQZ Biotechnologies Company, a biotechnology company, from April 2017 to March 2021, including Vice President of Finance. She has an experience leading management of finance and accounting for early to mid-stage private and public life science companies. She served as Director of Accounting & Finance for Agios including supporting the 2013 IPO. Alex held positions at both Molecular Insight Pharmaceuticals, a publicly-traded oncology company, acquired in 2013 and Coley Pharmaceuticals, a publicly-traded company developing immunotherapies for cancer and other disease areas, acquired by Pfizer in 2007. Alex earned her B.B.A in finance from the University of Massachusetts, Amherst and her M.B.A from Boston College. She is also a certified public accountant in Massachusetts. Ms. Balcom served as Corporate Controller at Agios Pharmaceuticals Inc., a pharmaceutical company.
Positions
- Company NameCrescent Biopharma, Inc.Stock CodeCBIOPositionIndependent DirectorColleagues
- JTJoshua T. BrummCEO & Director
- PEPeter Evan HarwinIndependent Chairman
- JMJonathan McNeillPresident & COO
- EIEllie ImChief Medical Officer
- RWRichard William ScalzoChief Financial Officer
- RLRyan LynchSenior VP of Finance, Treasurer & Chief Accounting Officer
- DCDavid Charles LubnerIndependent Director
- JVJonathan ViolinDirector
